NICE director Simon reports initial share, option stakes

Q: What does Zehava Simon report owning in NICE Ltd. (NCSYF) on this Form 3?

Zehava Simon reports direct ownership of 3,439 ordinary shares of NICE Ltd., plus various option grants over ordinary shares with different exercise prices and expiration dates. This Form 3 establishes her existing equity position as a director, not new buying or selling activity.

Q: Are any of Zehava Simon’s NICE Ltd. options already vested and exercisable?

Yes. A footnote states that at least one stock option is fully vested and currently exercisable. Other grants are also vested in part, with one grant scheduled to vest its remaining shares in three substantially equal installments during 2026, increasing her exercisable position over time.

Q: What are the exercise price ranges of Zehava Simon’s NICE Ltd. options?

The reported options over ordinary shares carry exercise prices from about 0.2657 per share up to 232.2005 per share. These differing strike levels reflect grants from various dates, with corresponding expiration dates between 2026 and 2031 for potential future exercises.

Q: Does this NICE Ltd. (NCSYF) Form 3 show insider buying or selling by Zehava Simon?

No. The Form 3 presents holdings information only, listing Simon’s existing ordinary shares and option positions. Transaction codes and summaries show no reported buys, sells, gifts or exercises, so this filing functions as a baseline disclosure of her current equity interests.

Q: Why is Zehava Simon’s Form 3 important for NICE Ltd. investors?

Form 3 gives investors a snapshot of a director’s initial equity stake in NICE Ltd., including shares and options. Knowing her direct ownership of 3,439 ordinary shares and multiple option grants helps assess alignment between board members and shareholders, even though no new trades are reported here.

NICE Ltd. director Zehava Simon filed an initial statement of beneficial ownership, outlining existing holdings in options and ordinary shares.

Filing Impact

(Neutral)

Filing Sentiment

(Neutral)

Form Type

Rhea-AI Filing Summary

NICE Ltd. director Zehava Simon filed an initial statement of beneficial ownership, outlining existing holdings in options and ordinary shares. The filing lists multiple option grants over ordinary shares with exercise prices ranging from 0.2657 to 232.2005 and expiration dates between 2026 and 2031. Footnotes state that some stock options are already fully vested and exercisable, while others vest over time, including one grant that vests in three substantially equal installments on March 30, 2026, June 30, 2026 and September 30, 2026. The filing also reports direct ownership of 3,439 ordinary shares, giving investors a clear view of the director’s current equity stake rather than any new transaction.

Insider Trade Summary

13 transactions reported

Mixed 13 txns

Insider Simon Zehava

Role Director

Type	Security	Shares	Price	Value
holding	Options	--	--	--
holding	Options	--	--	--
holding	Options	--	--	--
holding	Options	--	--	--
holding	Options	--	--	--
holding	Options	--	--	--
holding	Options	--	--	--
holding	Options	--	--	--
holding	Options	--	--	--
holding	Options	--	--	--
holding	Options	--	--	--
holding	Options	--	--	--
holding	Ordinary Shares	--	--	--

Holdings After Transaction: Options — 18,915 contracts (Direct); Ordinary Shares — 3,439 shares (Direct)

Footnotes (3)

F1. The stock option is fully vested and currently exercisable.
F2. The stock option is vested and exercisable with respect to 746 Ordinary Shares and will vest with respect to the remaining shares in three substantially equal installments on March 30, 2026, June 30, 2026 and September 30, 2026.
F3. The stock option will vest on September 30, 2026.

FAQ

What does Zehava Simon report owning in NICE Ltd. (NCSYF) on this Form 3?

Zehava Simon reports direct ownership of 3,439 ordinary shares of NICE Ltd., plus various option grants over ordinary shares with different exercise prices and expiration dates. This Form 3 establishes her existing equity position as a director, not new buying or selling activity.

Are any of Zehava Simon’s NICE Ltd. options already vested and exercisable?

Yes. A footnote states that at least one stock option is fully vested and currently exercisable. Other grants are also vested in part, with one grant scheduled to vest its remaining shares in three substantially equal installments during 2026, increasing her exercisable position over time.

How do the vesting schedules work for Zehava Simon’s NICE Ltd. options?

One option grant vests in three substantially equal installments on March 30, 2026, June 30, 2026 and September 30, 2026. Another footnote explains that a separate stock option will vest on September 30, 2026, showing a staged build-up of potential future share ownership.

What are the exercise price ranges of Zehava Simon’s NICE Ltd. options?

The reported options over ordinary shares carry exercise prices from about 0.2657 per share up to 232.2005 per share. These differing strike levels reflect grants from various dates, with corresponding expiration dates between 2026 and 2031 for potential future exercises.

Does this NICE Ltd. (NCSYF) Form 3 show insider buying or selling by Zehava Simon?

No. The Form 3 presents holdings information only, listing Simon’s existing ordinary shares and option positions. Transaction codes and summaries show no reported buys, sells, gifts or exercises, so this filing functions as a baseline disclosure of her current equity interests.

Why is Zehava Simon’s Form 3 important for NICE Ltd. investors?

Form 3 gives investors a snapshot of a director’s initial equity stake in NICE Ltd., including shares and options. Knowing her direct ownership of 3,439 ordinary shares and multiple option grants helps assess alignment between board members and shareholders, even though no new trades are reported here.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Understanding Insider Trading Forms →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google

Accepted by SEC EDGAR 03/18/2026 - 09:26 AM

SEC Form 3

FORM 3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0104
Estimated average burden
hours per response:			0.5

1. Name and Address of Reporting Person^*

Simon Zehava

(Last)

(First)

(Middle)

221 RIVER STREET

(Street)

HOBOKEN

NEW JERSEY

07030

(City)

(State)

(Zip)

UNITED STATES

(Country)

2. Date of Event Requiring Statement (Month/Day/Year)
03/18/2026

3. Issuer Name and Ticker or Trading Symbol
NICE Ltd. [ NICE ]

3a. Foreign Trading Symbol
[NICE.TA]

5. If Amendment, Date of Original Filed (Month/Day/Year)

4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director	10% Owner
	Officer (give title below)	Other (specify below)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	4. Nature of Indirect Beneficial Ownership (Instr. 5)
Ordinary Shares	3,439	D

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4)	2. Date Exercisable and Expiration Date (Month/Day/Year)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
1. Title of Derivative Security (Instr. 4)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
Options	⁽¹⁾	09/10/2026	Ordinary Shares	2,785	$224.18	D
Options	⁽¹⁾	09/10/2026	Ordinary Shares	696	$0.2929	D
Options	⁽¹⁾	04/28/2027	Ordinary Shares	554	$0.3076	D
Options	⁽¹⁾	04/28/2027	Ordinary Shares	2,214	$232.2005	D
Options	⁽¹⁾	06/22/2028	Ordinary Shares	2,516	$197.4245	D
Options	⁽¹⁾	06/22/2028	Ordinary Shares	629	$0.2887	D
Options	⁽¹⁾	07/17/2029	Ordinary Shares	521	$0.2751	D
Options	⁽¹⁾	07/17/2029	Ordinary Shares	2,086	$206.5232	D
Options	⁽¹⁾	07/03/2030	Ordinary Shares	2,545	$168.4643	D
Options	⁽¹⁾	07/03/2030	Ordinary Shares	636	$0.2657	D
Options	⁽²⁾	09/30/2031	Ordinary Shares	2,987	$144.903	D
Options	⁽³⁾	09/30/2031	Ordinary Shares	746	$0.3025	D

Explanation of Responses:

1. The stock option is fully vested and currently exercisable.

2. The stock option is vested and exercisable with respect to 746 Ordinary Shares and will vest with respect to the remaining shares in three substantially equal installments on March 30, 2026, June 30, 2026 and September 30, 2026.

3. The stock option will vest on September 30, 2026.

Remarks:

Exhibit 24 - Power of Attorney.

	/s/ Alon Levy, Attorney-in-Fact for Zehava Simon	03/18/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 3: SEC 1473 (03-26)

Source: View Original Filing on SEC EDGAR